You have 9 free searches left this month | for more free features.

stage IV nasopharyngeal cancer

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma, Stage IV Nasopharyngeal Carcinoma AJCC v8 Trial

Not yet recruiting
  • Metastatic Nasopharyngeal Carcinoma
  • +2 more
  • Nivolumab
  • +5 more
  • (no location specified)
Aug 21, 2023

Nasopharyngeal Carcinoma, Leucogen, Chemo Trial in Guangzhou (5-fu, Lobaplatin, Placebo)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • +3 more
  • Guangzhou, Guangdong, China
    Department of Radiation Oncology, Sun Yat-Sen University Cancer
Mar 10, 2023

Blood Tests and Questionnaires in Studying Adherence to

Recruiting
  • Carcinoma of Unknown Primary
  • +30 more
  • Biospecimen Collection
  • Questionnaire Administration
  • Houston, Texas
    M D Anderson Cancer Center
Dec 12, 2022

Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma, Stage IV Nasopharyngeal Carcinoma AJCC v8 Trial

Not yet recruiting
  • Metastatic Nasopharyngeal Carcinoma
  • +2 more
  • Biospecimen Collection
  • +5 more
  • (no location specified)
Jun 13, 2023

Clinical Stage II HPV-Mediated (p16-pos) Oropharyngeal Carcinoma, Clinical Stage III HPV-Mediated (p16-pos) Oropharyngeal

Not yet recruiting
  • Clinical Stage II HPV-Mediated (p16-pos) Oropharyngeal Carcinoma
  • +15 more
  • Best Practice
  • +9 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Aug 23, 2022

Stage II Nasopharyngeal Carcinoma AJCC v8, Stage III Nasopharyngeal Carcinoma AJCC v8, Stage IV Nasopharyngeal Carcinoma AJCC v8

Not yet recruiting
  • Stage II Nasopharyngeal Carcinoma AJCC v8
  • +2 more
  • Biopsy
  • +16 more
  • (no location specified)
Oct 7, 2023

Head and Neck Squamous Cell Carcinoma, Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma, Recurrent Nasopharynx

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +14 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 11, 2022

Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell

Active, not recruiting
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +29 more
  • Cytology specimen
  • Laboratory biomarker analysis
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Aug 31, 2021

Spatial Transcriptomics of Stage IVa Nasopharyngeal Carcinoma

Not yet recruiting
  • Stage IVA Nasopharyngeal Carcinoma
  • Intensity modulated radiation therapy (IMRT) combined with chemotherapy
  • Nanjing, China
    Jiangsu Cancer Hospital
Jun 21, 2023

Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,

Recruiting
  • Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +21 more
  • Atezolizumab
  • +8 more
  • Little Rock, Arkansas
  • +97 more
Jan 27, 2023

Nasopharyngeal Carcinoma Trial in Fuzhou (without concurrent cisplatin chemo, with concurrent cisplatin chemo)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • without concurrent cisplatin chemotherapy
  • with concurrent cisplatin chemotherapy
  • Fuzhou, Fujian, China
    Department of radiation oncology, Fujian cancer hospital
Oct 18, 2023

Nasopharyngeal Carcinoma, Nasopharyngeal Tumors, Nasopharyngeal Diseases Trial in Guangzhou (Nimotuzumab, Cisplatin)

Recruiting
  • Nasopharyngeal Carcinoma
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Nov 3, 2022

Nasopharyngeal Carcinoma Trial in Guangzhou (mobile platform or not mobile platform)

Recruiting
  • Nasopharyngeal Carcinoma
  • mobile platform or not mobile platform
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Apr 17, 2023

Nasopharyngeal Carcinoma Trial in San Francisco, Singapore (Nivolumab, Cisplatin, Radiation Therapy)

Recruiting
  • Nasopharyngeal Carcinoma
  • San Francisco, California
  • +1 more
Feb 7, 2022

Epstein-Barr Virus Positive, Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma Trial (Durvalumab,

Withdrawn
  • Epstein-Barr Virus Positive
  • +6 more
  • (no location specified)
Oct 22, 2020

Malignant Female Reproductive System Tumor, Stage III Cervical Cancer AJCC v8, Stage III Ovarian Cancer AJCC v8 Trial in Duarte

Not yet recruiting
  • Malignant Female Reproductive System Neoplasm
  • +10 more
  • Discussion
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Mar 24, 2023

Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8, Clinical

Not yet recruiting
  • Clinical Stage II Esophageal Adenocarcinoma AJCC v8
  • +11 more
  • Acupressure Therapy
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jun 12, 2023

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With

Completed
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +35 more
  • PI3K inhibitor BKM120
  • cetuximab
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Sep 14, 2021

Nasopharyngeal Carcinoma Trial in Beijing (Tislelizumab)

Recruiting
  • Nasopharyngeal Carcinoma
  • Beijing, Beijing, China
    National Cancer Center /National Clinical Research Center for Ca
Jul 4, 2022

Ovarian Cancer Trial in Birmingham (Carboplatin, olaparibp, embro)

Not yet recruiting
  • Ovarian Cancer
  • Birmingham, Alabama
    O'Neal Comprehensive Cancer Center at UAB
Jul 18, 2023

Non Small Cell Lung Cancer Metastatic Trial (MRI)

Not yet recruiting
  • Non Small Cell Lung Cancer Metastatic
  • MRI
  • (no location specified)
May 16, 2023

Stage III Fallopian Tube Cancer AJCC v7, Stage III Ovarian Cancer AJCC v6 and v7, Stage III Primary Peritoneal Cancer AJCC v7

Active, not recruiting
  • Stage III Fallopian Tube Cancer AJCC v7
  • +14 more
  • Minneapolis, Minnesota
  • +1 more
Jan 27, 2023

Colorectal Cancer Trial in Guangzhou (FOLFOX , FOLFIRI or FOLFOXIRI regimens, FOLFOX regimen)

Not yet recruiting
  • Colorectal Cancer
  • FOLFOX , FOLFIRI or FOLFOXIRI regimens
  • FOLFOX regimen
  • Guangzhou, Guangdong, China
    Nanfang Hospital, Southern Medical University
Apr 26, 2023

Advanced Nasopharyngeal Carcinoma Trial in Guangzhou (Toripalimab injection(subcutaneous)/JS001sc, Toripalimab /JS001)

Recruiting
  • Advanced Nasopharyngeal Carcinoma
  • Toripalimab injection(subcutaneous)/JS001sc
  • Toripalimab /JS001
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Feb 21, 2023

Stage I Colorectal Cancer AJCC v8, Stage II Colorectal Cancer AJCC v8, Stage IIA Colorectal Cancer AJCC v8 Trial in San

Completed
  • Stage I Colorectal Cancer AJCC v8
  • +12 more
  • Dietary Intervention
  • San Francisco, California
    Zuckerberg San Francisco General Hospital
Jan 5, 2023